|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/47 | (2006.01) |
| C07D 239/91 | (2006.01) |
| (11) | Number of the document | 2421533 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10714825.6 |
| Date of filing the European patent application | 2010-04-21 | |
| (97) | Date of publication of the European application | 2012-02-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation | 2018-12-27 |
| (86) | Number | PCT/US2010/031870 |
| Date | 2010-04-21 |
| (87) | Number | WO 2010/123975 |
| Date | 2010-10-28 |
| (30) | Number | Date | Country code |
| 171620 P | 2009-04-22 | US |
| (72) |
HANSEN, Henrik, C., CA
WAGNER, Gregory, S., US
ATTWELL, Sarah, C., CA
MCLURE, Kevin, G., CA
KULIKOWSKI, Ewelina, B., CA
|
| (73) |
Resverlogix Corp.,
300, 4820 Richard Road SW, Calgary, AB T3E 6L1,
CA
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Nauji priešuždegiminiai agentai |
| NOVEL ANTI-INFLAMMATORY AGENTS |
| Payment date | Validity (years) | Amount | |
| 2022-03-08 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-04-21 |